Accelerating treatments for ATP6AP2 and V-ATPase–related disorders — starting with one little boy named Luka.
We fund cutting-edge research, build global collaborations, and support families facing ultra-rare, proton pump–related diseases.
We fund cutting-edge research, build global collaborations, and support families facing ultra-rare, proton pump–related diseases.